Casi Pharmaceuticals (NASDAQ: CASI)
Casi Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Casi Pharmaceuticals Company Info
CASI Pharmaceuticals, Inc. engages in developing and commercializing therapeutics and pharmaceutical products. The company was founded on January 10, 2023 and is headquartered in Beijing, China.
News & Analysis
Why CASI Pharmaceuticals Is Crashing Today
Investors don't like that the company is hitting up the market for more cash.
Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today
Investors are pleased with a plan to sell generic Viread in China.
Here's Why CASI Pharmaceuticals Rose as Much as 31.6% Today
But it didn't last long.
Can These Top-Performing Biotech Stocks Keep Climbing?
Over the past year, these two biotech stocks outperformed nearly all their peers. Can they keep it going?
What Stocks Perform Well in the Midst of a Trade War?
With trade tensions heating up between the U.S. and China, here are some things to think about when it comes to the stock market.
Here's Why CASI Pharmaceuticals Rose as Much as 23.4% Today
The tiny biopharma announced progress for a drug application in China.
7 Surprising 5-Star Stocks
Stellar, or stinkers? The CAPS community sounds off.
5 More Top Small Caps
Are any of these going to be the next big thing?
Valuation
Earnings Transcripts
CASI Pharmaceuticals Inc (CASI) Q3 2020 Earnings Call Transcript
CASI earnings call for the period ending September 30, 2020.
CASI Pharmaceuticals Inc (CASI) Q2 2020 Earnings Call Transcript
CASI earnings call for the period ending June 30, 2020.
CASI Pharmaceuticals Inc (CASI) Q4 2019 Earnings Call Transcript
CASI earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.